Clinical Trial Results
Showing:
All studies
[change]
Condition: Hypertension
25 trials found
New Search
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RECRUITING
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
RECRUITING
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
RECRUITING
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RECRUITING
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RECRUITING
PAH Exercise Study
RECRUITING
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
RECRUITING
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
RECRUITING
Spironolactone for Pulmonary Arterial Hypertension
RECRUITING
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
RECRUITING
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
RECRUITING
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
RECRUITING
A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RECRUITING
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
RECRUITING
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
RECRUITING
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RECRUITING
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RECRUITING
To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
RECRUITING
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RECRUITING
Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension
RECRUITING
Xenon MRI Pulm Hypertension
RECRUITING
Bioenergetic Effect of Pioglitazone in CLD-PH
RECRUITING
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
RECRUITING
Repurposing Valsartan May Protect Against Pulmonary Hypertension
RECRUITING
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RECRUITING